News
News
- Biosplice Licenses Rights to Lorecivivint, a Novel Phase 3 Osteoarthritis Drug Candidate, to Samil for the Republic of Korea
17:36 - GlobeNewswire - Todos Medical Acquires Provista Diagnostics and Its Proprietary Videssa Breast Cancer Blood Test
17:35 - GlobeNewswire - Europe closes higher as ECB holds rates
17:31 - TeleTrader - Irish minister says legal action against AZ initiated
17:21 - TeleTrader - Just Energy Celebrates Earth Month Beyond April with Special Customer Promotions
17:10 - GlobeNewswire - Gallagher Announces Global Distribution Agreement with Invixium
17:00 - GlobeNewswire - Global Pandemic Fueled Renewed Investor Interest in Silver in 2020
17:00 - GlobeNewswire - Airrosti Expands Leadership Team as part of Strategic Growth Plan
17:00 - GlobeNewswire - Amarin Receives Great Britain Marketing Authorization for VAZKEPA from the Medicines and Healthcare Products Regulatory Agency (MHRA) 1,2
16:53 - GlobeNewswire - Biden to raise top marginal income, capital gains tax - report
16:46 - TeleTrader
Real-time